Covaxin shows 78% efficacy in Phase 3 interim analysis, says Bharat Biotech ...Middle East

Business Standard - News
Covaxin shows 78% efficacy in Phase 3 interim analysis, says Bharat Biotech
The Phase 3 study enrolled 25,800 participants between 18-98 years of age, including 10% over the age of 60, says the Hyderabad-based firm

Hence then, the article about covaxin shows 78 efficacy in phase 3 interim analysis says bharat biotech was published today ( ) and is available on Business Standard ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Covaxin shows 78% efficacy in Phase 3 interim analysis, says Bharat Biotech )

Apple Storegoogle play

Last updated :

Also on site :



Latest News